Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03014960
Other study ID # STUDY00000461-B
Secondary ID
Status Not yet recruiting
Phase N/A
First received January 5, 2017
Last updated October 24, 2017
Start date January 2018
Est. completion date June 2018

Study information

Verified date October 2017
Source University of Washington
Contact Yu Tse Heng
Phone 412-517-2941
Email yutse@uw.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to investigate the effects of sleep improvement in leaders on leader outcomes.


Description:

The investigators seek to extend the findings of a recent research which demonstrated that treating insomnia has several beneficial effects on employee work outcomes (Barnes, Miller, & Bostock, in press). In the present study, the investigators propose that the treatment of leader insomnia would beneficially influence leadership, specifically abusive supervision, charismatic leadership, and laissez-faire leadership.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 400
Est. completion date June 2018
Est. primary completion date June 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria:

- Working adults who have at least one direct report (i.e., subordinate).

Exclusion criteria:

- Non-working adults/ adults who do not have at least one direct report (i.e., subordinate).

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Online Cognitive Behavioral Therapy for Insomnia (CBT-I)
CBT-I is a psychological treatment designed to break the patterns of maladaptive thinking and behavior that maintain insomnia. CBT-I includes a range of techniques including a behavioral component (stimulus control, sleep restriction, relaxation) combined with a cognitive component (managing sleep related worries, the racing mind and intrusive thoughts) and an educational (sleep hygiene) component.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Washington

Outcome

Type Measure Description Time frame Safety issue
Primary Self-Control Scale Rate self-control over the past 2 weeks. Each item is scored 1-5 (1 = Very slightly or not at all, 2 = A little, 3 = Moderately, 4 = Quite a bit, 5 = Extremely). 2 weeks
Primary Abusive Supervision Scale Rate abusive supervision over the past 2 weeks. Each item is scored 1-5:
- I cannot remember him/her ever using this behavior with me
- He/she very seldom uses this behavior with me
- He/she occasionally uses this behavior with me
- He/she uses this behavior moderately often with me
- He/she uses this behavior very often with me
2 weeks
Primary Emotional Labor Scale Rate emotional labor over the past 2 weeks. Each item is scored 1-5 (1 = Very slightly or not at all, 2 = A little, 3 = Moderately, 4 = Quite a bit, 5 = Extremely). 2 weeks
Primary Charismatic Leadership Scale Rate charismatic leadership over the past 2 weeks. Each item is scored 1-5 (1 = to a very little extent; 2 = to a little extent; 3 = to a moderate extent; 4 = to a great extent; 5 = to a very great extent). 2 weeks
Primary Emotional Exhaustion Scale Rate emotional exhaustion over the past 2 weeks. Each item is scored 1-5 (1 = Very slightly or not at all, 2 = A little, 3 = Moderately, 4 = Quite a bit, 5 = Extremely). 2 weeks
Primary Laissez-Faire Leadership Scale Rate laissez-faire leadership over the past 2 weeks. Each item is scored 1-5 (1 = to a very little extent; 2 = to a little extent; 3 = to a moderate extent; 4 = to a great extent; 5 = to a very great extent). 2 weeks
Secondary Insomnia Scale Rate insomnia over the past 2 weeks. Each item is scored 1-5 (1 = Very slightly or not at all, 2 = A little, 3 = Moderately, 4 = Quite a bit, 5 = Very much) 2 weeks
See also
  Status Clinical Trial Phase
Completed NCT03171519 - Effects of Exercise and Acupuncture on Chronic Insomnia N/A
Completed NCT02515006 - Impact of Homeopathy for Persistent Insomnia in Patients With Cancer N/A
Recruiting NCT05247697 - Mirtazapine for Chronic Insomnia in Older Adults Phase 1
Active, not recruiting NCT04366284 - Optimizing the Scalability of Evidence-Based Behavioral Sleep Medicine Practices With a Digital Health Platform N/A
Active, not recruiting NCT04350866 - Enhancing Access to Insomnia Care in VA PCMHI Clinics
Recruiting NCT04761796 - Sleep Time and Insomnia Factors Among Professional Flight Members
Completed NCT02688569 - Sleep and Pain Intervention for Chronic Widespread Pain Pilot Study N/A
Completed NCT02236845 - Pilot Study to Clinical Evaluate Lacrima Medical Device in Insomnia Patients N/A
Completed NCT01949389 - Piloting an Internet-based Therapy for Insomnia in a Population of Veterans With Substance Use Disorders N/A
Completed NCT00414102 - Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia. Phase 4
Completed NCT00671294 - Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia. Phase 3
Completed NCT02392000 - Mobile Sleep Intervention for OEF, OIF and OND Veterans N/A
Recruiting NCT04471168 - Interest of Auriculotherapy in the Management of Chronic Insomnia N/A
Completed NCT02774642 - Integrated CBT-I and PE on Sleep and PTSD Outcomes (Impact Study) N/A
Completed NCT02290405 - Impact of Hyperarousal on Simple and Complex Cognitive Task Performance Among Insomnia Sufferers
Completed NCT05618002 - Lemborexant vs Zopiclone vs Clonidine for Insomnia Treatment in Chronic Pain Patients
Completed NCT01995838 - A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic Insomnia Phase 2
Recruiting NCT05457790 - Feasibility and Preliminary Efficacy of Acceptance and Commitment Therapy (ACT) for Sleep Disturbances in Adults With Sickle Cell Disease (SCD) N/A
Completed NCT02272712 - The Effectiveness of Online Treatment for Insomnia in Cancer Survivors N/A
Completed NCT00915135 - Efficacy and Safety of Ramelteon on Chronic Insomnia Phase 2